Agile Therapeutics slips after bigger Q1 loss

Agile Therapeutics

05/05/2021 12:53

** Drug developer's shares  AGRX.O  up 3.2% at $1.55
premarket 
    ** Co's quarterly net loss widens to $17.1 mln from $7.9 mln
a year ago, pressured by its investments in the launch of its
contraceptive patch, Twirla  urn:newsml:reuters.com:*:nGNXbND94m
    ** AGRX says lower sales of Twirla were due to wholesalers
working down inventory levels after initial stocking of the drug
in the fourth quarter 
    ** Twirla revenue of $0.1 mln for the quarter likely caught
some by surprise, but underlying launch remains positive - RBC
Capital Markets 
    ** Stock has fallen ~40% YTD 

 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24))